Abstract

Kelch repeat and BTB domain-containing protein 11 (KBTBD11) is a member of the KBTBD subfamily of proteins that possess a BTB domain and Kelch repeats. Despite the presence of the Kbtbd11 gene in mammalian genomes, there are few reports about KBTBD11 at present. In this study, we identified the novel protein KBTBD11 as a negative regulator of osteoclast differentiation. We found that expression of KBTBD11 increased during osteoclastogenesis. Small-interfering-RNA-mediated knockdown of KBTBD11 enhanced osteoclast formation, and markedly increased the expression of several osteoclast marker genes compared with control cells. Conversely, KBTBD11 overexpression impaired osteoclast differentiation, and decreased the expression of osteoclast marker genes. Among six major signaling pathways regulating osteoclast differentiation, KBTBD11 predominantly influenced the nuclear factor of activated T cell cytoplasmic-1 (NFATc1) pathway. Mechanistically, KBTBD11 was found to interact with an E3 ubiquitin ligase, Cullin3. Further experiments involving immunoprecipitation and treatment with MG132, a proteasome inhibitor, showed that the KBTBD11–Cullin3 promotes ubiquitination and degradation of NFATc1 by the proteasome. Considering that NFATc1 is an essential factor for osteoclast differentiation, the KBTBD11 and Cullin3 probably regulate the levels of NFATc1 through the ubiquitin-proteasome degradation system. Thus, KBTBD11 negatively modulates osteoclast differentiation by controlling Cullin3-mediated ubiquitination of NFATc1.

Details

Title
KBTBD11, a novel BTB-Kelch protein, is a negative regulator of osteoclastogenesis through controlling Cullin3-mediated ubiquitination of NFATc1
Author
Narahara Shun 1 ; Sakai Eiko 2 ; Kadowaki Tomoko 3 ; Yamaguchi, Yu 2 ; Narahara Haruna 2 ; Okamoto Kuniaki 4 ; Asahina Izumi 5 ; Tsukuba Takayuki 2   VIAFID ORCID Logo 

 Graduate School of Biomedical Sciences, Nagasaki University, Department of Dental Pharmacology, Nagasaki, Japan (GRID:grid.174567.6) (ISNI:0000 0000 8902 2273); Graduate School of Biomedical Sciences, Nagasaki University, Department of Regenerative Oral Surgery, Nagasaki, Japan (GRID:grid.174567.6) (ISNI:0000 0000 8902 2273) 
 Graduate School of Biomedical Sciences, Nagasaki University, Department of Dental Pharmacology, Nagasaki, Japan (GRID:grid.174567.6) (ISNI:0000 0000 8902 2273) 
 Graduate School of Biomedical Sciences, Nagasaki University, Department of Frontier Life Science, Nagasaki, Japan (GRID:grid.174567.6) (ISNI:0000 0000 8902 2273) 
 Graduate School of Biomedical Sciences, Nagasaki University, Department of Dental Pharmacology, Nagasaki, Japan (GRID:grid.174567.6) (ISNI:0000 0000 8902 2273); Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Department of Dental Pharmacology, Okayama, Japan (GRID:grid.261356.5) (ISNI:0000 0001 1302 4472) 
 Graduate School of Biomedical Sciences, Nagasaki University, Department of Regenerative Oral Surgery, Nagasaki, Japan (GRID:grid.174567.6) (ISNI:0000 0000 8902 2273) 
Publication year
2019
Publication date
Dec 2019
Publisher
Nature Publishing Group
e-ISSN
20452322
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2188201770
Copyright
This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.